211 related articles for article (PubMed ID: 7935496)
1. Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.
Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Little M
Mol Immunol; 1994 Oct; 31(14):1047-58. PubMed ID: 7935496
[TBL] [Abstract][Full Text] [Related]
2. Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines.
Kipriyanov SM; Dübel S; Breitling F; Kontermann RE; Heymann S; Little M
Cell Biophys; 1995 Jun; 26(3):187-204. PubMed ID: 8521451
[TBL] [Abstract][Full Text] [Related]
3. Variable region sequence modulates periplasmic export of a single-chain Fv antibody fragment in Escherichia coli.
Ayala M; Balint RF; Fernández-de-Cossío L; Canaán-Haden JW; Larrick JW; Gavilondo JV
Biotechniques; 1995 May; 18(5):832, 835-8, 840-2. PubMed ID: 7619489
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of recombinant single chain Fv antibody that recognizes platelet glycoprotein Ibalpha.
Dai K; Zhu H; Ruan C
Thromb Res; 2003 Jan; 109(2-3):137-44. PubMed ID: 12706643
[TBL] [Abstract][Full Text] [Related]
5. Construction, expression, purification, refold and activity assay of a specific scFv fragment against foot and mouth disease virus.
ShengFeng C; Ping L; Tao S; Xin W; GuoFeng W
Vet Res Commun; 2003 Apr; 27(3):243-56. PubMed ID: 12777098
[TBL] [Abstract][Full Text] [Related]
6. Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv).
Dübel S; Breitling F; Kontermann R; Schmidt T; Skerra A; Little M
J Immunol Methods; 1995 Jan; 178(2):201-9. PubMed ID: 7836782
[TBL] [Abstract][Full Text] [Related]
7. Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand.
Albrecht H; Burke PA; Natarajan A; Xiong CY; Kalicinsky M; DeNardo GL; DeNardo SJ
Bioconjug Chem; 2004; 15(1):16-26. PubMed ID: 14733579
[TBL] [Abstract][Full Text] [Related]
8. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.
Marty C; Scheidegger P; Ballmer-Hofer K; Klemenz R; Schwendener RA
Protein Expr Purif; 2001 Feb; 21(1):156-64. PubMed ID: 11162401
[TBL] [Abstract][Full Text] [Related]
9. Design and expression of a stable bispecific scFv dimer with affinity for both glycophorin and N9 neuraminidase.
Atwell JL; Pearce LA; Lah M; Gruen LC; Kortt AA; Hudson PJ
Mol Immunol; 1996 Dec; 33(17-18):1301-12. PubMed ID: 9171890
[TBL] [Abstract][Full Text] [Related]
10. Recognition of E. coli tryptophan synthase by single-chain Fv fragments: comparison of PCR-cloning variants with the parental antibodies.
Brégégère F; England P; Djavadi-Ohaniance L; Bedouelle H
J Mol Recognit; 1997; 10(4):169-81. PubMed ID: 9476520
[TBL] [Abstract][Full Text] [Related]
11. Affinity enhancement of a recombinant antibody: formation of complexes with multiple valency by a single-chain Fv fragment-core streptavidin fusion.
Kipriyanov SM; Little M; Kropshofer H; Breitling F; Gotter S; Dübel S
Protein Eng; 1996 Feb; 9(2):203-11. PubMed ID: 9005442
[TBL] [Abstract][Full Text] [Related]
12. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
[TBL] [Abstract][Full Text] [Related]
13. Production and in vitro refolding of a single-chain antibody specific for human plasma apolipoprotein A-I.
Cho WK; Sohn U; Kwak JW
J Biotechnol; 2000 Feb; 77(2-3):169-78. PubMed ID: 10682277
[TBL] [Abstract][Full Text] [Related]
14. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
[TBL] [Abstract][Full Text] [Related]
15. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
Albrecht H; Denardo GL; Denardo SJ
J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921
[TBL] [Abstract][Full Text] [Related]
16. A single chain Fv specific against Western equine encephalitis virus.
Xu B; Kriangkum J; Nagata LP; Fulton RE; Suresh MR
Hybridoma; 1999 Aug; 18(4):315-23. PubMed ID: 10571261
[TBL] [Abstract][Full Text] [Related]
17. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment.
Nieba L; Honegger A; Krebber C; Plückthun A
Protein Eng; 1997 Apr; 10(4):435-44. PubMed ID: 9194169
[TBL] [Abstract][Full Text] [Related]
18. Leucine zipper dimerized bivalent and bispecific scFv antibodies from a semi-synthetic antibody phage display library.
de Kruif J; Logtenberg T
J Biol Chem; 1996 Mar; 271(13):7630-4. PubMed ID: 8631798
[TBL] [Abstract][Full Text] [Related]
19. Novel single-chain Fv' formats for the generation of immunoliposomes by site-directed coupling.
Messerschmidt SK; Kolbe A; Müller D; Knoll M; Pleiss J; Kontermann RE
Bioconjug Chem; 2008 Jan; 19(1):362-9. PubMed ID: 17988079
[TBL] [Abstract][Full Text] [Related]
20. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly.
Wörn A; Plückthun A
FEBS Lett; 1998 May; 427(3):357-61. PubMed ID: 9637257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
